These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 13294150)

  • 1. [Neutral salts of a disulfuric ester of 4-methylesculetol (MG 1039) with 1-phenyl-2, 3-dimethyl-4-dimethylamino-5-pyrazolone].
    CAVALLINI G; MILLA E; GRUMELLI E; MASSARANI E; MAZZUCCHI F
    Farmaco Sci; 1955; 10(10):699-709. PubMed ID: 13294150
    [No Abstract]   [Full Text] [Related]  

  • 2. [Our experience with sodium 1, 5-dimethyl-2-phenyl-4-dimethylamino-3-pyrazolone sulfonate in suppositories as postoperative analgesic in gynecology].
    ELIAS COSTA JD
    Prensa Med Argent; 1955 Nov; 42(44):3384-5. PubMed ID: 13310471
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the analgesic effect of 1-phenyl-2,3-dimethyl-4-isopropyl-5-pyrazolone].
    BAUER G
    Arzneimittelforschung; 1959 Jul; 9():401-3. PubMed ID: 13848953
    [No Abstract]   [Full Text] [Related]  

  • 4. Pyrazolone derivatives.
    Brogden RN
    Drugs; 1986; 32 Suppl 4():60-70. PubMed ID: 3552586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [BRONCHIAL ASTHMA IN PYRAZOLONE HYPERSENSITIVITY].
    MEISTER W
    Allerg Asthma (Leipz); 1963 Jul; 9():151-3. PubMed ID: 14075976
    [No Abstract]   [Full Text] [Related]  

  • 6. [Combination of N-butylhyoscine bromide & a pyrazolone derivative in the treatment of colic].
    MORENO DE VEGA V
    Rev Clin Esp; 1957 Nov; 67(3):163-9. PubMed ID: 13527940
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experimental studies on the action of a pyrazolone derivative on smooth-musculed organs].
    LINDNER E
    Arzneimittelforschung; 1956 Mar; 6(3):124-7. PubMed ID: 13315078
    [No Abstract]   [Full Text] [Related]  

  • 8. Spasmolytic effects of pyrazolone drugs.
    Forth W
    Agents Actions Suppl; 1986; 19():169-75. PubMed ID: 3463175
    [No Abstract]   [Full Text] [Related]  

  • 9. [Bismuth salts of the disulfuric ester of 4-methylesculetol. I. Pharmacodynamic aspects].
    Rugarli P; Olivi A
    Boll Chim Farm; 1965 Nov; 104(11):710-29. PubMed ID: 5880972
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the precursors and formation of methylrubazonic acid after ingestion of amidopyrine together with a review on the degradation of dimethylamino-phenyl-dimethyl-pyrazolone].
    Preuss FR; Voigt KM
    Arzneimittelforschung; 1965 Jul; 15(7):741-7. PubMed ID: 5324709
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacological actions of a salt of aminophenazone: cyclohexylsulfamate of 1-phenyl-2,3-dimethyl-4-dimethylamino-5-pyrazolone. I. Toxicity and analgesic activity].
    Mucci P; Bertolini A; Sternieri E
    Boll Soc Ital Biol Sper; 1965 Mar; 41(5):235-9. PubMed ID: 5876877
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of oxidation agents on 4-dimethylamino-1-phenyl-2,3-dimethyl-5-pyrazolone. Splitting of dimethylamine as 1st step in the effect of oxidation agents on 4-dimethylpyrazolone of the pyramidon type and characterization of the 1st transformation product].
    AWE W; STOY-GEILICH E; BUERHOP R; BAMMEL H
    Arzneimittelforschung; 1960 Oct; 10():796-800. PubMed ID: 13685319
    [No Abstract]   [Full Text] [Related]  

  • 13. [Control of various pharmaceutical products. I. Disulfuric esters of 4-methylesculetol and of 2-methyl-1, 4-naphthohydroquinone].
    BANCHETTI A
    Farmaco Sci; 1955; 10(12):970-9. PubMed ID: 13294178
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacological actions of a salt of aminophenazone: cyclohexylsulfamate of 1-phenyl-2,3-dimethyl-4-dimethylamino-5-pyrazolone. II. Antiphlogistic and antipyretic activity].
    Mucci P; Bertolini A; Sternieri E
    Boll Soc Ital Biol Sper; 1965 Mar; 41(5):239-43. PubMed ID: 5876878
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacological and clinical observations on the combination of N-butyl-bromide of hyoscine and phenyldimethyl-pyrazolone-methylamino-methanesulfonate of sodium (buscopan compositum)].
    MARINO A; MURARO U
    Rass Int Clin Ter; 1959 Dec; 39():1333-56. PubMed ID: 14421164
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of human neutrophil oxidative burst by pyrazolone derivatives.
    Costa D; Marques AP; Reis RL; Lima JL; Fernandes E
    Free Radic Biol Med; 2006 Feb; 40(4):632-40. PubMed ID: 16458194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does pyrazolone-induced renal injury exist?
    Mihatsch MJ
    Agents Actions Suppl; 1986; 19():247-66. PubMed ID: 3463182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combined use of bucolome and pyrazolone derivatives (1). Pharmacological activities and blood concentration].
    Nozaki M
    Nihon Yakurigaku Zasshi; 1975 Sep; 71(6):609-29. PubMed ID: 281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ion exchange and spectrophotometry in organic-pharmaceutical analysis. Part 2. Determination of pyrazolones and alkaloidal bases in mixtures containing both].
    HAEBERLI E; BEGUIN E
    Pharm Acta Helv; 1960; 35():13-21. PubMed ID: 13830788
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the pharmacology of 4-(N-nicotinoylaminoacetylamino)-1-phenyl-2,3-dimethyl-pyrazolone-(5) HCI].
    EDER H; ANSARI PM; PREUSSER G; RAMMNER U
    Arzneimittelforschung; 1961 Nov; 11():1043-6. PubMed ID: 13889170
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.